NCT04567667View on ClinicalTrials.gov

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

April 11, 2021

Study Completion Date

April 11, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

[14C] BMS-986278

Specified dose on specified days

DRUG

Kinevac®

Specified dose on specified days

Trial Locations (1)

53704

Covance - Clinical Pharmacology Services - Madison, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04567667 - Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants | Biotech Hunter | Biotech Hunter